Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 1846 AL 1858

Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology

Singh S.

Int J Neurosci. 2020 Mar;130(3):251-261. doi: 10.1080/00207454.2019.1667799. Epub 2019 Oct 13.

Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment

Dandachi-FitzGerald B, Duits AA, Leentjens AFG, Verhey FRJ, Ponds RWHM.

J Int Neuropsychol Soc. 2020 Mar;26(3):314-321. doi: 10.1017/S1355617719001139. Epub 2019 Oct 29.

Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients

Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario G, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB.

Eur J Neurol. 2020 Mar;27(3):475-483. doi: 10.1111/ene.14117. Epub 2019 Dec 18.

GIP has neuroprotective effects in Alzheimer and Parkinson's disease models

Zhang ZQ, Hölscher C.

Peptides. 2020 Mar;125:170184. doi: 10.1016/j.peptides.2019.170184. Epub 2019 Nov 6.

Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation

Jakobs M, Lee DJ, Lozano AM.

Neuropharmacology. 2020 Jul;171:107860. doi: 10.1016/j.neuropharm.2019.107860. Epub 2019 Nov 23.

The microbiome-gut-brain axis in acute and chronic brain diseases

Benakis C, Martin-Gallausiaux C, Trezzi JP, Melton P, Liesz A, Wilmes P.

Curr Opin Neurobiol. 2020 Apr;61:1-9. doi: 10.1016/j.conb.2019.11.009. Epub 2019 Dec 6.

The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias

Ciafone J, Little B, Thomas AJ, Gallagher P.

J Int Neuropsychol Soc. 2020 Feb;26(2):210-225. doi: 10.1017/S1355617719001103. Epub 2019 Dec 12.

Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases

Wang Y, Yang Y, Zhang S, Li C, Zhang L.

Neurobiol Aging. 2020 Mar;87:1-10. doi: 10.1016/j.neurobiolaging.2019.12.013. Epub 2019 Dec 20.

Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case report

Caillaud M, Laisney M, Bejanin A, Scherer-Gagou C, Bonneau D, Duclos H, Eustache F, Verny C, Desgranges B, Allain P.

Neurocase. 2020 Feb;26(1):36-41. doi: 10.1080/13554794.2019.1696837. Epub 2019 Nov 26.

RNA toxicity in non-coding repeat expansion disorders

Swinnen B, Robberecht W, Van Den Bosch L.

EMBO J. 2020 Jan 2;39(1):e101112. doi: 10.15252/embj.2018101112. Epub 2019 Nov 13.

Hallucinatory palinopsia and paroxysmal oscillopsia as initial manifestations of sporadic Creutzfeldt-Jakob disease: A case study

Lahiri D, Dubey S, Ray BK, Ardila A.

Cortex. 2020 Mar;124:188-192. doi: 10.1016/j.cortex.2019.11.017. Epub 2019 Dec 13.

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Cacabelos R.

Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.

The nature of decision-making in people living with dementia: a systematic review

Bhatt J, Walton H, Stoner CR, Scior K, Charlesworth G.

Aging Ment Health. 2020 Mar;24(3):363-373. doi: 10.1080/13607863.2018.1544212. Epub 2018 Dec 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias